| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://ppubs.uspto.gov/api/pdf/downloadPdf/12469610?requestToken=eyJzdWIiOiIzZTQ5MWI5NS0wZjI4LTQwYjQtOGIyNS05ZmVhNTU3MDU1MjYiL...
electroCore (NASDAQ:ECOR) sees FY2025 sales of $31.500 million-$32.500 million vs $30.749 million analyst estimate.
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 29...
electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCor...